SARS Testing Underway After Development Of Two Diagnostics
This article was originally published in The Gray Sheet
Executive Summary
Newly developed severe acute respiratory syndrome (SARS) diagnostics assays are being tested and refined, according to the World Health Organization
You may also be interested in...
CDC Assessing Accuracy Of SARS Diagnostis; Future Virus Mutations Expected
The Centers for Disease Control & Prevention has begun production and widespread distribution of reagents for the diagnosis of the Severe Acute Respiratory Syndrome (SARS) virus, Gen-Probe Chief Scientist Daniel Kacian MD/PhD explained during a Merrill Lynch conference call April 10
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.